Another study found that a high CD8+/CD4+ ratio and a low FOXP3/CD8 ratio correlate with prolonged survival of PD-L1+ patients but not for that of PD-L1− patients with esophageal cancer [26]. This evidence concerns the gene CD8A and esophageal cancer.